Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Chubb
Fuji
Johnson and Johnson
Colorcon
US Army
Fish and Richardson
Mallinckrodt
Baxter

Generated: August 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 079179

« Back to Dashboard

NDA 079179 describes IMATINIB MESYLATE, which is a drug marketed by Apotex Inc, Dr Reddys Labs Ltd, Mylan Pharms Inc, Sun Pharma Global, Teva Pharms Usa, and West-ward Pharms Int, and is included in six NDAs. It is available from eleven suppliers. Additional details are available on the IMATINIB MESYLATE profile page.

The generic ingredient in IMATINIB MESYLATE is imatinib mesylate. There are thirty-three drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the imatinib mesylate profile page.
Summary for 079179
Tradename:IMATINIB MESYLATE
Applicant:Apotex Inc
Ingredient:imatinib mesylate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 079179
Mechanism of ActionProtein Kinase Inhibitors
Medical Subject Heading (MeSH) Categories for 079179
Suppliers and Packaging for NDA: 079179
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IMATINIB MESYLATE imatinib mesylate TABLET;ORAL 079179 ANDA AvKARE, Inc. 42291-351 N 42291-351-90
IMATINIB MESYLATE imatinib mesylate TABLET;ORAL 079179 ANDA AvKARE, Inc. 42291-352 N 42291-352-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 100MG BASE
Approval Date:Aug 5, 2016TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 400MG BASE
Approval Date:Aug 5, 2016TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Boehringer Ingelheim
Queensland Health
AstraZeneca
Argus Health
McKesson
Dow
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.